These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 10882699

  • 1. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
    Ackermann G, Schaumann R, Pless B, Claros MC, Rodloff AC.
    J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of HMR 3647 against anaerobic bacteria.
    Edlund C, Sillerström E, Wahlund E, Nord CE.
    J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM, Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.
    Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrel KL, Fernandez H.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1963-7. PubMed ID: 12760875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
    Boswell FJ, Andrews JM, Ashby JP, Fogarty C, Brenwald NP, Wise R.
    J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D, Robbins MJ, Marais R, Ridgway GL, Gruneberg RN.
    Drugs Exp Clin Res; 1987 Dec; 13(4):195-9. PubMed ID: 3113907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of cefotetan against anaerobic bacteria.
    Dias MB, Jacobus NV, Tally FP, Gorbach SL.
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):359-63. PubMed ID: 3457672
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA, Rotimi VO, Jamal WY, Shahin M, Verghese TL.
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of Bay Y3118 against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.